Tert expression in pituitary adenomas | Zendy

Nuray Can | Zendy; Mehmet Çelik | Zendy; Buket Yılmaz Bülbül | Zendy; Necdet Süt | Zendy; Filiz Özyılmaz | Zendy; Semra Aytürk | Zendy; Sibel Güldiken | Zendy; Nurtaç Sarıkaş | Zendy; Fulya Öz Puyan | Zendy; Tülin Yalta | Zendy; Ali Kutlu | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Tert expression in pituitary adenomas

Author(s) -

Nuray Can,

Mehmet Çelik,

Buket Yılmaz Bülbül,

Necdet Süt,

Filiz Özyılmaz,

Semra Aytürk,

Sibel Güldiken,

Nurtaç Sarıkaş,

Fulya Öz Puyan,

Tülin Yalta,

Ali Kutlu

Publication year - 2017

Publication title -

turkish journal of pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.305

H-Index - 14

eISSN - 1309-5730

pISSN - 1018-5615

DOI - 10.5146/tjpath.2016.01387

Subject(s) - immunohistochemistry , pathology , pituitary adenoma , pituitary gland , adenoma , cytoplasm , medicine , biology , hormone , biochemistry

Although pituitary adenomas have benign histomorphological features, some of them may present in an aggressive manner. To predict the behaviour of these tumours, telomerase reverse transcriptase (TERT) activity in pituitary adenomas has been the subject of a few studies with contradictory results. This study aims to investigate whether immunohistochemical expression of TERT differs in neoplastic and nonneoplastic pituitary tissues and aims to investigate whether TERT expression is related to clinicopathological features of pituitary adenomas.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research